![Ken Herrmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Herrmann
Direttore/Membro del Consiglio presso
AKTIS ONCOLOGY, INC.
Patrimonio netto: - $ in data 30/06/2026
Profilo
Ken Herrmann currently holds the position of Chairman-Department of Nuclear Medicine at Universitätsmedizin Essen since 2016.
Dr. Herrmann is also a Director at SOFIE Co., Sofie Biosciences, Inc., and Theragnostics Ltd. (since 2021).
In 2024, Dr. Herrmann became an Independent Director at Aktis Oncology, Inc. and a Member of the Supervisory Board at Pentixapharm Holding AG.
Dr. Herrmann earned an MBA from the University of Zurich in 2011 and holds a doctorate from Charité - Universitätsmedizin Berlin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
AKTIS ONCOLOGY, INC. -.--% | 20/07/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Ken Herrmann
| Società | Posizione | Inizio |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/05/2024 |
Sofie Biosciences, Inc.
 Sofie Biosciences, Inc. Medical SpecialtiesHealth Technology Engages in production and distribution of molecular diagnostic and therapeutics | Direttore/Membro del Consiglio | - |
Theragnostics Ltd.
 Theragnostics Ltd. Medical SpecialtiesHealth Technology Develops and distributes diagnostic devices & therapeutics | Direttore/Membro del Consiglio | 01/07/2021 |
SOFIE Co.
 SOFIE Co. Pharmaceuticals: MajorHealth Technology Provides full service radiopharmaceuticals to the nuclear medicine industry | Direttore/Membro del Consiglio | - |
Formazione di Ken Herrmann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
SOFIE Co.
SOFIE Co. Pharmaceuticals: MajorHealth Technology Provides full service radiopharmaceuticals to the nuclear medicine industry | Health Technology |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Charité - Universitätsmedizin Berlin
 Charité - Universitätsmedizin Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sofie Biosciences, Inc.
Sofie Biosciences, Inc. Medical SpecialtiesHealth Technology Engages in production and distribution of molecular diagnostic and therapeutics | Health Technology |
Theragnostics Ltd.
Theragnostics Ltd. Medical SpecialtiesHealth Technology Develops and distributes diagnostic devices & therapeutics | Health Technology |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
